Status:
COMPLETED
Study on Incentives for Glaucoma Medications Adherence
Lead Sponsor:
Duke-NUS Graduate Medical School
Collaborating Sponsors:
Singapore National Eye Centre
Conditions:
Glaucoma
Eligibility:
All Genders
21-85 years
Phase:
NA
Brief Summary
Glaucoma topical eye medications, when adhered to, are effective at controlling disease progression. Yet evidence shows that many glaucoma patients have incomplete adherence to medications, with disea...
Detailed Description
By reducing intraocular pressure, glaucoma topical eye medications are effective at controlling disease progression for the majority of patients. Yet evidence shows that many glaucoma patients have in...
Eligibility Criteria
Inclusion
- Singaporean citizens or permanent residents
- Conversant in English or Mandarin
- Taking at least one glaucoma eye drop medication
- Shown to be non-adherent based on a value of 6 or less on the Modified Medication Adherence Scale (MMAS)
Exclusion
- Significant comorbid conditions preventing application of medications without assistance
- Stage 4 (advanced) or Stage 5 (end stage) glaucoma according to the Glaucoma Staging System
Key Trial Info
Start Date :
November 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 1 2017
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT02271269
Start Date
November 1 2014
End Date
February 1 2017
Last Update
May 1 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Singapore National Eye Center
Singapore, Singapore